Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS)
Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Listed as NCT04481555, this PHASE4 trial focuses on Azithromycin and COPD and remains completed. Sponsored by Chronic Obstructive Pulmonary Disease Trial Network, Denmark, it has been updated 11 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Apr 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 6 earlier versions
-
Mar 2024 — Apr 2024 [monthly]
Recruiting PHASE4
-
Sep 2023 — Mar 2024 [monthly]
Recruiting PHASE4
-
Sep 2022 — Sep 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .